{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:43:18Z","timestamp":1795095798372,"version":"4.10.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:00:00Z","timestamp":1556323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5584-6","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T15:03:51Z","timestamp":1556377431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples"],"prefix":"10.1186","volume":"19","author":[{"given":"Falk","family":"Zakrzewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gieldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Gr\u00fctzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Zeugner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Hackmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Porrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Baretton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin","family":"Schr\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Klink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,27]]},"reference":[{"key":"5584_CR1","doi-asserted-by":"crossref","unstructured":"Schroeder C, Faust U, Sturm M, Hackmann K, Grundmann K, Harmuth F, et al. HBOC multi-gene panel testing: comparison of two sequencing centers. Breast Cancer Res. Treat. [Internet]. 2015 [cited 2017 Apr 12];152:129\u201336. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26022348","DOI":"10.1007\/s10549-015-3429-9"},{"key":"5584_CR2","doi-asserted-by":"crossref","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA [Internet]. American Medical Association; 2017 [cited 2018 Jan 29];317:2402. Available from: http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2017.7112","DOI":"10.1001\/jama.2017.7112"},{"key":"5584_CR3","doi-asserted-by":"crossref","unstructured":"Kast K, Rhiem K, Wappenschmidt B, Hahnen E, Hauke J, Bluemcke B, et al. Prevalence of BRCA1\/2 germline mutations in 21 401 families with breast and ovarian cancer. J. Med. Genet. [Internet]. 2016 [cited 2018 Jan 29];53:465\u201371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26928436","DOI":"10.1136\/jmedgenet-2015-103672"},{"key":"5584_CR4","doi-asserted-by":"crossref","unstructured":"Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. [Internet]. 2007 [cited 2017 Apr 18];8:735\u201348. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17768402","DOI":"10.1038\/nrg2159"},{"key":"5584_CR5","doi-asserted-by":"crossref","unstructured":"Gudmundsdottir K, Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene [Internet]. 2006 [cited 2017 Apr 18];25:5864\u201374. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16998501","DOI":"10.1038\/sj.onc.1209874"},{"key":"5584_CR6","doi-asserted-by":"publisher","unstructured":"Koh KH, Kang HJ, Li LS, Kim N-G, You KT, Yang E, et al. Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas. Lab. Investig. [Internet]. Nature Publishing Group; 2005 [cited 2017 Sep 13];85:1130\u20138. Available from: https:\/\/doi.org\/10.1038\/labinvest.3700315","DOI":"10.1038\/labinvest.3700315"},{"key":"5584_CR7","doi-asserted-by":"publisher","unstructured":"Rump A, Benet-Pages A, Schubert S, Kuhlmann JD, Janavi\u010dius R, Mach\u00e1\u010dkov\u00e1 E, et al. Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer. Eng C, editor. PLOS Genet. [Internet]. Public Library of Science; 2016 [cited 2017 Aug 28];12:e1006248. Available from: https:\/\/doi.org\/10.1371\/journal.pgen.1006248","DOI":"10.1371\/journal.pgen.1006248"},{"key":"5584_CR8","doi-asserted-by":"publisher","unstructured":"Hackmann K, Kuhlee F, Betcheva-Krajcir E, Kahlert A-K, Mackenroth L, Klink B, et al. Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH. Breast Cancer Res. Treat. [Internet]. Springer US; 2016 [cited 2017 Mar 21];159:585\u201390. Available from: https:\/\/doi.org\/10.1007\/s10549-016-3956-z","DOI":"10.1007\/s10549-016-3956-z"},{"key":"5584_CR9","doi-asserted-by":"crossref","unstructured":"Petersen AH, Aagaard MM, Nielsen HR, Steffensen KD, Waldstr\u00f8m M, Bojesen A. Post-mortem testing; germline BRCA1\/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling. Eur. J. Hum. Genet. [Internet]. Nature Publishing Group; 2016 [cited 2017 Apr 12];24:1104\u201311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26733283","DOI":"10.1038\/ejhg.2015.268"},{"key":"5584_CR10","doi-asserted-by":"publisher","unstructured":"de Jong LC, Cree S, Lattimore V, Wiggins GAR, Spurdle AB, Miller A, et al. Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events. Breast Cancer Res [Internet] BioMed Central; 2017 [cited 2017 Dec 13];19:127. Available from: https:\/\/doi.org\/10.1186\/s13058-017-0919-1 .","DOI":"10.1186\/s13058-017-0919-1"},{"key":"5584_CR11","doi-asserted-by":"publisher","unstructured":"Rosenbloom KR, Armstrong J, Barber GP, Casper J, Clawson H, Diekhans M, et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res. [Internet]. Oxford University Press; 2015 [cited 2017 Aug 2];43:D670\u201381. Available from: https:\/\/doi.org\/10.1093\/nar\/gku1177","DOI":"10.1093\/nar\/gku1177"},{"key":"5584_CR12","doi-asserted-by":"publisher","unstructured":"Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature [Internet]. Nature Publishing Group; 2001 [cited 2017 Aug 2];409:860\u2013921. Available from: https:\/\/doi.org\/10.1038\/35057062","DOI":"10.1038\/35057062"},{"key":"5584_CR13","doi-asserted-by":"publisher","unstructured":"Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet [Internet] Nature Publishing Group; 1996 [cited 2017 Aug 2];12:333\u20137. Available from. https:\/\/doi.org\/10.1038\/ng0396-333 .","DOI":"10.1038\/ng0396-333"},{"key":"5584_CR14","doi-asserted-by":"crossref","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science [Internet]. 1994 [cited 2017 Aug 2];266:66\u201371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7545954","DOI":"10.1126\/science.7545954"},{"key":"5584_CR15","doi-asserted-by":"publisher","unstructured":"B\u00e9roud C, Letovsky SI, Braastad CD, Caputo SM, Beaudoux O, Bignon YJ, et al. BRCA Share: A Collection of Clinical BRCA Gene Variants. Hum. Mutat. [Internet]. 2016 [cited 2017 Aug 28];37:1318\u201328. Available from: https:\/\/doi.org\/10.1002\/humu.23113","DOI":"10.1002\/humu.23113"},{"key":"5584_CR16","doi-asserted-by":"crossref","unstructured":"Pikor LA, Enfield KSS, Cameron H, Lam WL. DNA extraction from paraffin embedded material for genetic and epigenetic analyses. J Vis Exp. [Internet]. MyJoVE Corporation; 2011 [cited 2017 Mar 21]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21490570 .","DOI":"10.3791\/2763"},{"key":"5584_CR17","doi-asserted-by":"crossref","unstructured":"Tang W, David FB, Wilson MM, Barwick BG, Leyland-Jones BR, Bouzyk MM. DNA extraction from formalin-fixed, paraffin-embedded tissue. Cold Spring Harb Protoc. [Internet]. Cold Spring Harbor Laboratory Press; 2009 [cited 2017 Mar 21];2009:pdb.prot5138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20147068 .","DOI":"10.1101\/pdb.prot5138"},{"key":"5584_CR18","unstructured":"QIAGEN. Biomedical Genomics Workbench [Internet]. 2017. Available from: https:\/\/www.qiagenbioinformatics.com\/products\/clc-genomics-workbench ."},{"key":"5584_CR19","doi-asserted-by":"crossref","unstructured":"Sims D, Sudbery I, Ilott NE, Heger A, Ponting CP. Sequencing depth and coverage: key considerations in genomic analyses. Nat. Rev. Genet. [Internet]. Nature Publishing Group; 2014 [cited 2018 27];15:121\u201332. Available from: http:\/\/www.nature.com\/articles\/nrg3642 .","DOI":"10.1038\/nrg3642"},{"key":"5584_CR20","unstructured":"R Core Team. R: A language and environment for statistical computing [Internet]. 2017. Available from: http:\/\/www.r-project.org\/ ."},{"key":"5584_CR21","doi-asserted-by":"publisher","unstructured":"Povysil G, Tzika A, Vogt J, Haunschmid V, Messiaen L, Zschocke J, et al. panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics. Hum. Mutat. [Internet]. 2017 [cited 2017 Jun 15];38:889\u201397. Available from: https:\/\/doi.org\/10.1002\/humu.23237 .","DOI":"10.1002\/humu.23237"},{"key":"5584_CR22","doi-asserted-by":"publisher","unstructured":"Klambauer G, Schwarzbauer K, Mayr A, Clevert D-A, Mitterecker A, Bodenhofer U, et al. cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate. Nucleic Acids Res. [Internet]. Oxford University Press; 2012 [cited 2017 Mar 21];40:e69\u2013e69. Available from: https:\/\/doi.org\/10.1093\/nar\/gks003","DOI":"10.1093\/nar\/gks003"},{"key":"5584_CR23","doi-asserted-by":"crossref","unstructured":"Bartels S, Schipper E, Hasemeier B, Kreipe H, Lehmann U. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms. Oncotarget [Internet]. Impact Journals, LLC; 2016 [cited 2017 Dec 1];7:30084\u201393. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029036","DOI":"10.18632\/oncotarget.8310"},{"key":"5584_CR24","doi-asserted-by":"publisher","unstructured":"Ward DG, Baxter L, Gordon NS, Ott S, Savage RS, Beggs AD, et al. Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer. Real FX, editor. PLoS One [Internet]. Public Library of Science; 2016 [cited 2018 Dec 27];11:e0149756. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0149756","DOI":"10.1371\/journal.pone.0149756"},{"key":"5584_CR25","doi-asserted-by":"crossref","unstructured":"Munchel S, Hoang Y, Zhao Y, Cottrell J, Klotzle B, Godwin AK, et al. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics. Oncotarget [Internet]. Impact Journals, LLC; 2015 [cited 2017 Dec 1];6:25943\u201361. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26305677","DOI":"10.18632\/oncotarget.4671"},{"key":"5584_CR26","doi-asserted-by":"crossref","unstructured":"Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, et al. Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists. J. Mol. Diagn. [Internet]. Elsevier; 2017 [cited 2017 Dec 1];19:341\u201365. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28341590","DOI":"10.1016\/j.jmoldx.2017.01.011"},{"key":"5584_CR27","doi-asserted-by":"crossref","unstructured":"Clarke LA, Rebelo CS, Gon\u00e7alves J, Boavida MG, Jordan P. PCR amplification introduces errors into mononucleotide and dinucleotide repeat sequences. Mol Pathol. [Internet]. BMJ Publishing Group; 2001 [cited 2017 Sep 1];54:351\u20133. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11577179 .","DOI":"10.1136\/mp.54.5.351"},{"key":"5584_CR28","doi-asserted-by":"crossref","unstructured":"Do H, Dobrovic A. Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization. Clin Chem [Internet] 2014 [cited 2017 Aug 28];61. Available from: http:\/\/clinchem.aaccjnls.org\/content\/61\/1\/64.long .","DOI":"10.1373\/clinchem.2014.223040"},{"key":"5584_CR29","doi-asserted-by":"crossref","unstructured":"Adsay V, Ohike N, Tajiri T, Kim GE, Krasinskas A, Balci S, et al. Ampullary Region Carcinomas. Am. J. Surg. Pathol. [Internet]. 2012 [cited 2017 Aug 7];36:1592\u2013608. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23026934","DOI":"10.1097\/PAS.0b013e31826399d8"},{"key":"5584_CR30","doi-asserted-by":"crossref","unstructured":"Arreaza G, Qiu P, Pang L, Albright A, Hong LZ, Marton MJ, et al. Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) Samples. Int. J. Mol. Sci. [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); 2016 [cited 2017 Apr 12];17. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27657050","DOI":"10.3390\/ijms17091579"},{"key":"5584_CR31","doi-asserted-by":"crossref","unstructured":"McCall CM, Mosier S, Thiess M, Debeljak M, Pallavajjala A, Beierl K, et al. False positives in multiplex PCR-based next-generation sequencing have unique signatures. J. Mol. Diagn. [Internet]. American Society for Investigative Pathology; 2014 [cited 2017 Dec 13];16:541\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25017478","DOI":"10.1016\/j.jmoldx.2014.06.001"},{"key":"5584_CR32","doi-asserted-by":"crossref","unstructured":"Yu YP, Michalopoulos A, Ding Y, Tseng G, Luo J-H. High fidelity copy number analysis of formalin-fixed and paraffin-embedded tissues using Affymetrix Cytoscan HD chip. PLoS One [Internet]. Public Library of Science; 2014 [cited 2017 Dec 1];9:e92820. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24699316","DOI":"10.1371\/journal.pone.0092820"},{"key":"5584_CR33","unstructured":"Oliveira C, Wolf T. CNVPanelizer: Reliable CNV detection in targeted sequencing applications [internet]. R Packag. version 1.6.0. 2017 [cited 2017 Jan 1]. Available from: https:\/\/www.bioconductor.org\/packages\/devel\/bioc\/html\/CNVPanelizer.html ."},{"key":"5584_CR34","doi-asserted-by":"crossref","unstructured":"Singh RR, Patel KP, Routbort MJ, Aldape K, Lu X, Manekia J, et al. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours. Br. J. Cancer [Internet]. Nature Publishing Group; 2014 [cited 2017 Dec 13];111:2014\u201323. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25314059 .","DOI":"10.1038\/bjc.2014.518"},{"key":"5584_CR35","doi-asserted-by":"crossref","unstructured":"Seifert M, Gohr A, Strickert M, Grosse I. Parsimonious Higher-Order Hidden Markov Models for Improved Array-CGH Analysis with Applications to Arabidopsis thaliana. Noble WS, editor. PLoS Comput. Biol. [Internet]. 2012 [cited 2017 Jun 14];8:e1002286. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22253580 .","DOI":"10.1371\/journal.pcbi.1002286"},{"key":"5584_CR36","doi-asserted-by":"crossref","unstructured":"Seifert M, Abou-El-Ardat K, Friedrich B, Klink B, Deutsch A. Autoregressive Higher-Order Hidden Markov Models: Exploiting Local Chromosomal Dependencies in the Analysis of Tumor Expression Profiles. Najbauer J, editor. PLoS One [Internet]. 2014 [cited 2017 Jun 14];9:e100295. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24955771","DOI":"10.1371\/journal.pone.0100295"},{"key":"5584_CR37","doi-asserted-by":"crossref","unstructured":"Dziadkowiec KN, G\u0105siorowska E, Nowak-Markwitz E, Jankowska A. PARP inhibitors: review of mechanisms of action and BRCA1\/2 mutation targeting. Prz. menopauzalny = Menopause Rev. [Internet]. Termedia Publishing; 2016 [cited 2018 Jan 29];15:215\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28250726","DOI":"10.5114\/pm.2016.65667"},{"key":"5584_CR38","doi-asserted-by":"crossref","unstructured":"Konecny GE, Kristeleit RS. PARP inhibitors for BRCA1\/2-mutated and sporadic ovarian cancer: current practice and future directions. Br. J. Cancer [Internet]. Nature Publishing Group; 2016 [cited 2018 Jan 29];115:1157\u201373. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27736844","DOI":"10.1038\/bjc.2016.311"},{"key":"5584_CR39","doi-asserted-by":"crossref","unstructured":"Kim Y, Kim A, Sharip A, Sharip A, Jiang J, Yang Q, et al. Reverse the Resistance to PARP Inhibitors. Int. J. Biol. Sci. [Internet]. Ivyspring International Publisher; 2017 [cited 2018 Jan 29];13:198\u2013208. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28255272","DOI":"10.7150\/ijbs.17240"},{"key":"5584_CR40","doi-asserted-by":"crossref","unstructured":"Pruthi S, Gostout BS, Lindor NM. Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin. Proc. [Internet]. Mayo Foundation; 2010 [cited 2018 Jan 29];85:1111\u201320. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21123638","DOI":"10.4065\/mcp.2010.0414"},{"key":"5584_CR41","doi-asserted-by":"crossref","unstructured":"Pal T, Vadaparampil ST. Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting. Cancer Control [Internet]. NIH Public Access; 2012 [cited 2018 Jan 29];19:255\u201366. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23037493","DOI":"10.1177\/107327481201900402"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5584-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5584-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5584-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:35:24Z","timestamp":1663374924000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5584-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5584"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5584-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,27]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research has been approved by the Ethics Committee of Medizinische Fakult\u00e4t der Technischen Universit\u00e4t Dresden by \u201cErgebnisforschung im Kontext des Famili\u00e4ren Brust- und Eierstockkrebs\u201d der Klinik und Poliklinik f\u00fcr Frauenheilkunde und Geburtshilfe des Universit\u00e4tsklinikums Dresden\/Medizinische Fakult\u00e4t \u201cCarl Gustav Carus\u201d, Technischen Universit\u00e4t Dresden\" (reference number: EK162072007) and by \"Feingewebliche, immunohistologische und molekularpathologische Untersuchungen in langzeit-archiviertem Gewebsmaterial des Institutes f\u00fcr Pathologie des Universit\u00e4tsklinikums Dresden\/Medizinische Fakult\u00e4t \u201cCarl Gustav Carus\u201d, Technischen Universit\u00e4t Dresden \"(reference number: EK59032007). The Ethics Committee of Medizinische Fakult\u00e4t der Technischen Universit\u00e4t Dresden bases its assessment of the submitted study on the guidelines of the revised declaration of the World Medical Association of Helsinki in the respectively valid version, on the Pharmaceutical Code, on the Radiation Protection Ordinance and on the generally recognized guidelines for \u201cICH-GCP E6\u201d. The authors confirm that a written declaration of consent has been obtained from all patients prior to the genetic examination according to the German Gene Diagnosis Act (GenDG). No identifiable personal patient data is displayed in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent to publish family trees displayed in Fig.of this work has been obtained from respective participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PW is advisory board member of AstraZeneca and got honoraria for scientific talks.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"396"}}